Curaleaf Reports Q4 2025 Revenue Growth Amid Pricing Pressures
Event summary
- Curaleaf reported Q4 2025 revenue of $333 million, up 5% sequentially and 2% year-over-year.
- International revenue grew 65% year-over-year to $51 million in Q4 2025.
- Adjusted gross margin expanded to 49%, up 20 basis points from the previous year.
- Full-year 2025 revenue reached $1.27 billion with adjusted EBITDA of $275 million.
- Company closed a $500 million debt offering to repay outstanding notes and extend loan maturity.
The big picture
Curaleaf's Q4 2025 results highlight its ability to grow despite a challenging pricing environment, driven by international expansion and operational efficiencies. The company's strategic shift from stabilization to acceleration, supported by a $500 million debt offering, positions it to capitalize on market opportunities while managing financial constraints. The focus on brand-led innovation and enhanced execution will be critical in sustaining organic growth and evaluating potential acquisitions.
What we're watching
- Market Expansion
- How Curaleaf's international growth will impact overall revenue diversification.
- Cost Optimization
- Whether productivity gains in cultivation can offset persistent pricing pressures.
- Financial Strategy
- The pace at which debt refinancing will improve the company's financial flexibility.
Related topics